The report is based on the market historical data from 2012 to 2016 and forecast the market trend from 2017 to 2022.

This report focuses on the U.S. market and presents volume and value of market share by players, by regions, by product type, by consumers and also changes in prices. As an in-depth report, it covers all details inside analysis and opinions in Synthetic Biology industry.

Major Companies
Amyris, Inc. (U.S.)
DowDuPont (U.S.)
GenScript USA Inc. (U.S.)
Intrexon Corporation (U.S.)
Integrated DNA Technologies (IDT) (U.S.)
New England Biolabs, Inc. (NEB) (U.S.)
Novozymes (Denmark)
Royal DSM (Netherlands)
Synthetic Genomics, Inc (California)
Thermo Fisher Scientific, Inc. (U.S.)

Key Regions
North America
United States
California
Texas
New York
Others
Canada
Latin America
Mexico
Brazil
Argentina
Others
Europe
Germany
United Kingdom
France
Italy
Spain
Russia
Netherland
Others
Asia & Pacific
China
Japan
India
Korea
Australia
Southeast Asia
Indonesia
Thailand
Philippines
Vietnam
Singapore
Malaysia
Others
Africa & Middle East
South Africa
Egypt
Turkey
Saudi Arabia
Iran
Others

Main types of products
Synthetic Biology Market, by Iool
Xeno-nucleic Acids (XNA)
Oligonucleotides
Chassis Organisms
Enzymes
Cloning and Assembly kits
Synthetic Biology Market, by Technology
Enabling Technologies
Enabled Technologies

Synthetic Biology Market, by Key Consumers
Environmental Application
Medical Application
Industrial Application